INTRODUCTION
IBD is classified to two typical phenotypes, namely ulcerative colitis and Crohn' s disease. Although the precise etiologies of IBD remain obscure, several reports have indicated that dysfunctions of the mucosal immune system play important roles in its pathogenesis. 1 The gastrointestinal tract is continuously exposed to a variety of antigens including enteric bacteria and foods. However, homeostasis of the gut is maintained in the normal state without the development of intestinal inflammation, by suppressing excessive immune responses to foreign antigens. In both innate and acquired immunity, the disruption of regulatory mechanisms may www.gut.or.kr play a key role in bacterial recognition and elimination, as well as in the polarization of innate and adaptive immunity. Besides these classical antibacterial immune roles, it has recently become evident that macrophages are also important for the maintenance of homeostasis, for example, inflammation dampening via the production of anti-inflammatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-β , debris scavenging, angiogenesis, and wound repair. [2] [3] [4] Recent studies have shown that M1 and M2 macrophages are functionally polarized in response to microorganisms and host mediators. M1 macrophages are characterized by the production of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α , IL-12, and IL-23, while M2 macrophages are characterized as IL-10 producing macrophages. 3 Interestingly, it was previously reported that intestinal macrophages have immune-regulatory functions. In contrast to splenic macrophages, intestinal macrophages do not express innate response receptors, 5, 6 and although these cells retain their phagocytic and bactericidal functions, they do not produce pro-inflammatory cytokines in response to several inflammatory stimuli, including microbial components. 7, 8 Importantly, we and other groups have revealed that murine intestinal macrophages produce the anti-inflammatory cytokine, IL-10 (M2 macrophage) and contribute to maintain homeostasis of the intestinal immune system. Hirotani et al. 9 demonstrated that wild type colonic lamina propria macrophages (LP-Mφ s), were different from splenic macrophages, as they produced higher amounts of IL-10 in response to pathogen associated molecular patterns. Kamada et al. 8 also demonstrated that in vitro macrophage colony-stimulating factor (M-CSF) differentiated macrophages isolated from bone marrow CD11b + monocytes (M-Mφ s) and intestinal CD11b + macrophages produced abundant IL-10 in response to whole bacteria stimulation. In addition, the number of intestinal macrophages in M-CSF-deficient op/op mice was significantly decreased. 10 Collectively, wild type mice intestinal macrophages have an IL-10 producing phenotype as well as in vitro differentiated M-Mφ s. Thus, these results suggest that intestinal macrophages in wild type mice are of the IL-10 producing M2 type and may contribute to homeostasis maintenance. Uniquely, Takada et al. 11 analyzed CD11b+ LP-Mφ s from mice and demonstrated they could be divided to two sub-populations (LP-Mφ 1 and LP-Mφ 2) by flow cytometry analysis. LP-Mφ 2 expressed CCR2 and produced large amounts of IL-10. Interestingly, MCP-1 −/− mice contained fewer LP-Mφ 2 cells resulting in the exacerbation of dextran sodium sulfate (DSS) induced colitis. Thus, LP-Mφ s contribute to the maintenance of gut immune homeostasis by producing IL-10. LP-Mφ s may have antigen presenting functions and induce the differentiation of FoxP3 + T regulatory cells that are dependent on IL-10 and retinoic acid. 12 Thus, recent studies have suggested that macrophages located in the intestinal mucosa play important roles in the maintenance of intestinal homeostasis by protecting the host from foreign pathogens and negatively regulating excess immune responses to commensals. 13 
Role of Intestinal Macrophages in the Pathogenesis of Crohn's Disease
Immune homeostasis in the gut is disrupted when intestinal macrophage function is dysregulated, resulting in chronic intestinal inflammation. IL-10 deficient (IL-10 −/− ) mice develop spontaneous chronic colitis and are widely used as an animal colitis model for human IBD.
14 IL-10 −/− mice develop Th1 polarized immunity in response to the intestinal microbiota evidenced by the observation that IL-10 −/− mice do not develop intestinal inflammation in germ-free conditions. 15 This suggests that enteric bacteria play an essential role in the onset and development of colitis in IL-10 −/− mice, which may also be the case in human IBD. Recent studies demonstrated that antigen presenting cells, such as macrophages and dendritic cells (DCs), from IL-10 −/− mice were potent activators of Th1 responses, 16 and importantly, depletion of macrophages prevented chronic colitis in IL-10 −/− mice. 17 These data suggest that macrophages and DCs play a key role in the pathogenesis of colitis in IL-10 −/− mice. We previously demonstrated that in vivo LP-Mφ s from IL-10 −/− mice showed a paradoxical overproduction of IL-12p70 upon bacterial stimuli. −/− M-CSF-induced macrophages was significantly reduced by exogenous IL-10 during differentiation. 8 These results indicated that endogenous IL-10 inhibited IL12p70 production and functionally regulated macrophages towards an anti-inflammatory phenotype. Interestingly, whole bacteria are potent inducers of macrophage IL-12p70 production compared with cell surface components such as lipopolysaccharide (LPS) in this model. Whole bacteria stimulation strongly induced signal transducers and activator of transcription (STAT)-1 activation. Significant repression of IL-12p70 production was achieved by inhibition of phagocytosis. 18 These observations suggested that intracellular pathogen recognition and signaling are involved in the induction of IL-12p70 in IL-10 −/− macrophages. Granuloma formation is a pathological characteristic of human Crohn' s disease. Mizoguchi et al. 19 demonstrated that F4/80-positive immature CD11c The contribution of intestinal macrophages that express triggering receptor expressed on myeloid cells 1 (TREM-1) to the pathogenesis in a murine experimental colitis model and patients with IBD has been reported. 13 We reported that LP-Mφ s produce large amounts of IL-18 and promote Th1 immune responses in Crohn' s disease. 20 Recently, we identified the infiltration of unique CD14 + intestinal macrophages (CD14 + Mφ s) in the mucosa during Crohn's disease. 21 This subset expressed both macrophage (CD14, CD33, CD68) and DC markers (CD205, CD209) and produced larger amounts of proinflammatory cytokines, such as IL-23, TNF-α , and IL-6, than typical intestinal resident macrophages. In patients with Crohn' s disease, the number of CD14 + Mφ s was significantly increased compared with normal control subjects. In addition to increased numbers of cells, these cells also produced larger amounts of IL-23 and TNF-α in response to whole bacteria stimulation. 21 Th1 immune responses predominate in Crohn' s disease, and CD4 + T cells in the LP of Crohn' s disease expressed T-bet and produced large amounts of interferon (IFN)-γ . 22 Macrophage-derived IL-23 strongly enhanced IFN-γ production by lamina propria mononuclear cells (LPMCs) in Crohn' s disease. 21 Thus, macrophage-derived IL-23 is a key cytokine for the predominance of Th1 responses in Crohn' s disease. CD14 + Mφ s also have antigen presenting functions and can stimulate the differentiation and proliferation of naïve CD4 + T cells obtained from peripheral blood. 23 Importantly, although in vitro differentiated DCs cannot induce the differentiation of peripheral blood naïve CD4 + T cells to Th17 cells, lamina propria CD14 + Mφ s from Crohn' s disease patients can strongly induce T cell differentiation to both Th1 and Th17 cells by whole bacteria stimulation. 23 The differentiation of Th17 cells is dependent upon IL-1β and IL-6, but not IL-23, produced by CD14 + Mφ s. These findings are consistent with previous observations that showed the difference in requirement of cytokines to promote the polarization of Th17 cells between humans and mice. 24 TL1A/TNFSF15, a member of the TNF superfamily was identified as a susceptibility gene for Crohn' s disease especially in Japanese patients. 25 ,26 CD14 + macrophages in Crohn' s disease express membrane binding of TL1A/TNFSF15 that acts synergistically with IL-23 to promote the production of IFN-γ and IL-17 by LPMCs. 27 Both T cells and mucosal NK cells in Crohn' s disease have the potential to produce IFN-γ . 21, 28 Thus, CD14 + Mφ s are central in the promotion of an inflammatory cytokine network at mucosal sites and are involved in the pathogenesis of Crohn' s disease (Fig. 1). 
Conditioning and Control of Differentiation of Innate Immune Cells
As well as T cells, innate immune cells such as macrophages and DCs are a therapeutic target in IBD. Especially in Crohn' s disease, the conditioning or regulation of differentiation of innate immune cells to a regulatory or a proinflammatory cytokine hypo-producing phenotype could be a therapeutic target. IL-12 and IL-23 are key cytokines that promote Th1 and Th17 immune response. Therefore, suppression of production of these cytokines is a promising therapy for Crohn's disease as well as molecular targeting therapy by monoclonal antibodies. 29, 30 Tetomilast (OPC-6535), originally developed to inhibit superoxide production, suppressed TNF-α and IL-12 but not IL-10 production from LPS-stimulated human monocytes and ameliorated chronic colitis in IL-10 −/− mice. 31 Histidine inhibited LPS-induced TNF-α and IL-6 production by mouse macrophages and dietary histidine ameliorated colitis in a IL-10 −/− mouse transfer colitis model. 32 Interestingly, amino acid profiling revealed decreased levels of plasma histidine concentration in the patients with active Crohn' s disease. 33 We have demonstrated that several molecules can affect the differentiation of monocytes to DCs. Am80, a synthetic retinoic acid receptor (RAR) agonist, promotes the differentiation of monocytes to an IL-12p70 hypo-producing DC phenotype with a reduced Th1 polarizing ability. Am80 treatment ameliorated DSS-induced colitis in mice. 34 Bile acids and a synthetic agonist can also induce the differentiation of monocytes to IL-12p70 hypo-producing DCs by signaling through TGR5, a member of the rhodopsin-like superfamily of transmembrane G-protein coupled receptors. 35 These molecules may be candidate therapeutic targets for Th1 dominant inflammatory disorders such as Crohn' s disease.
TH17 CELLS IN INTESTINAL HOMEOSTASIS AND INFLAMMATION

Are Th17 Cells Pathogenic in Gut Mucosal
Immunology?
The hypothesis of a Th1/Th2 cytokine balance has been used to explain the pathogenesis of chronic inflammatory disorders such as IBD. However, the recent discovery of a new class of Th cells, Th17 cells, which produce IL-17 family cytokines, raised a new paradigm that Th17 cells are an essential T cell subpopulation in the development of chronic inflammatory disorders in humans and mice. It is thought that each Th subpopulation is independently generated in the presence of specific transcription factors. In mice, Th17 cells are generated from naïve T cells in the presence of TGF-β and IL-6 and express a specific transcription factor, retinoic acidrelated orphan receptor (ROR)γ t. [36] [37] [38] [39] Recent reports suggest that the combination of IL-6, IL-23, and IL-1β effectively induce IL-17 production in naive T cells, independently of TGF-β . 40 In humans, the mechanism of Th17 development is more complicated. It is difficult to induce Th17 cells from naïve peripheral blood T cells using in vitro differentiated conventional DCs even in the presence of TGF-β and IL-6. AcostaRodriguez et al. 24 reported that IL-1β and IL-6 are essential for the development of Th17 cells in humans. However, Manel et al. 41 succeeded in inducing Th17 cells from naïve T cells obtained from cord blood in the presence of TGF-β , IL-1β , and IL-21 or IL-23.
Th17 cells play a significant role in the pathogenesis of murine colitis models. IL-23p19 transgenic mice spontaneously developed chronic colitis. 42 In IL-10 −/− mice, which develop chronic Th1/Th17 dominant colitis, IL-23 administration exacerbated intestinal inflammation. 43 The transfer of IL-17A-producing Th17 cells from C3Bir mice caused severe chronic colitis in the severe combined immunodeficiency mice, which was inhibited by anti-IL-23p19 monoclonal antibody (mAb) treatment. 44 Recombination activating gene (RAG)-1 −/− mice transferred with CD4 + CD25-T cells from RORγ t −/− mice did not develop colitis. 45 These findings suggest that Th17 cells may contribute to the pathogenesis of chronic intestinal inflammation. However, it is still controversial whether IL-17A plays a pathological role in colitis. Administration of neutralizing anti-IL-17A mAb did not reduce the severity of colitis in an adaptive transfer model of CD4 + CD45RB high T cells. 43 However, the administration of neutralizing anti-IL-17A mAbs exacerbated DSS-induced colitis. 46 Furthermore, RAG-1 −/− mice reconstituted with CD45RB high T cells from IL-17 receptor-deficient mice exhibited an accelerated wasting disease. 47 In addition, IL-17A induced colitis in RAG-1 −/− mice transferred with CD4 + CD25 − T cells from RORγ t −/− mice. 45 IL-17 receptor-deficient mice were protected from acute trinitrobenzene sulfonic acid-induced colitis. 48 Thus, the contribution of Th17 cells in the pathogenesis colitis remains unresolved. It has become evident that Th17 cells can be classified in several subpopulations according to their cytokine profile. McGeachy et al. 49 reported that Th17 cells could be divided to two types: Th17 cells producing IL-17 and IL-10, and Th17 cells developed under IL-23 stimulation producing IL-17 and pro-inflammatory cytokines. Furthermore, recent studies have suggested interactions between Th1 and Th17 cells. IL-17A suppressed a murine model of colitis by blocking the development of Th1 cells. 47 We demonstrated the existence of interference between colitogenic Th1 and Th17 cells in vivo. We co-transferred CD4 + T cells from colitic RAG-2 −/− mice with CD4 + CD45RB high cells from colitic IL-10 −/− mice into naive RAG-2 −/− mice. The proportions of IFN-γ and IL-17A producing CD4 + T cells in co-transferred mice were significantly decreased compared with single-cell transferred mice. 50 To date, although it is thought that each Th subpopulation is generated independently, the current progress of immunology research has highlighted the plasticity between these Th cell lineages. Lee 52 Collectively, these results indicate a distinct developmental pathway from Th17 to alternative Th1 cells via Th17/Th1 and Th1-like cells during colitis (Fig. 2) .
Th17 Cells in Human IBD
The pathological role of Th17 cells in human IBD remains unclear. To increase our understanding, we should consider the difference in the functional roles of Th17 cells between mice models and human diseases as reviewed by Steinman. 53 Fujino et al. 54 reported that IL-17A expression is upregulated in CD3 + T cells and CD68 + macrophages in the inflamed mucosa of patients with IBD. We previously reported that CD14 + Mφ in the inflamed mucosa of Crohn' s disease patients produced IL-23, IL-6, TNF-α , and TL1A/TNFSF15 in response to whole bacteria stimulation and induced the differentiation of naïve T cells to both Th1 and Th17 cells. 21, 23, 27 In Crohn' s disease especially, IL-23 strongly induced IFN-γ production from T cells and NK cells. 21, 28 In contrast, we also demonstrated that IL-23 enhanced Th17 immunological responses in ulcerative colitis. 55 To date, the contribution of Th17 cells to human IBD pathogenesis is controversial. Indeed, the efficacy of anti-IL17A mAb has not been proven in patients with IBD.
Mucosal NK Cells as a Novel Factor in IBD Pathogenesis
NK cells play an important role in systemic immunosurveillance to protect hosts from neoplasms and infections. NK cells can rapidly detect and dispose of target cells such as tumor cells and infected cells. NK cells also contribute to immunity by producing several types of cytokines such as IFN-γ and TNF-α . Recently, mucosal NK cells were shown to be involved in homeostasis at mucosal sites. 56, 57 We previously indentified that numbers of mucosal NK cells were increased in the LP of Crohn' s disease. 58 We found increased numbers of c-kit + lineage markers (lin)-cells in human adult intestine. These intestinal immune precursors expressed CD34, CD38, CD33, IL-2Rα , and IL-7Rα . The lin-c-kit + precursors mainly differentiated to CD56 + c-kit dim cells in vitro corresponding to intestinal NK cells, which are clearly distinguished from peripheral blood NK cells by expression patterns of surface molecules and cytokine production. These cells produced higher amounts of IFN-γ , while their cytotoxic activity was relatively low. Interestingly, both c-kitdim cells and NK cells were increased in the inflamed mucosa of Crohn' s disease. 58 
CONCLUSIONS
Intensive research in intestinal mucosal immunology has recently suggested several new paradigms such as the importance of Th17 immunity, the identification of several subpopulations of intestinal antigen presenting cells, and the identification of a new immune cell population. However, we should also recognize that we still have an incomplete picture of the pathogenesis of IBD. There is still a long way to go, but we confidently expect that the recent advances in 
